BitFuFu sees Q1 setbacks but rebounds with hashrate growth, efficiency gains, and rising cloud mining users. Click to read ...

FormFactor offers AI exposure with a halved stock price, but resistance and value concerns suggest caution ahead. See why ...

Over the last decade there has been an extraordinary increase in our knowledge of the fundamental molecular processes that are involved in the development of cancer and its response to treatment ...

Figure 1: Varying the antigen dose affects the magnitude of the CD8 + T cell response and the recruitment of naïve CD8 + T cells, but all recruited cells divide extensively. Figure 2: CD8 + T ...

Story May 13 - Leap Therapeutics: The Massachusetts-based biotech is halving its headcount while narrowing the focus of its lead cancer drug. The company entered 2025 with 52 full-time staffers ...